Đang chuẩn bị liên kết để tải về tài liệu:
Pioglitazone use and risk of bladder cancer: An in vitro study
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Whether pioglitazone (PIO), a peroxisome proliferator-activated receptor-gamma agonist, increases the risk of developing bladder cancer has been debated for several years. The aim of this study was to investigate the in vitro effects of PIO on normal urothelial transitional epithelium (NUTE) cells and bladder cancer (J82) cells to further evaluate the risk. | Pioglitazone use and risk of bladder cancer: An in vitro study